E Fund Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8,503
| Closed | -$500K | – | 387 |
|
|
2023
Q4 | $500K | Sell |
8,503
-4,320
| -34% | -$254K | 0.03% | 168 |
|
|
2023
Q3 | $559K | Buy |
12,823
+1,063
| +9% | +$46.3K | 0.04% | 114 |
|
|
2023
Q2 | $425K | Buy |
11,760
+1,913
| +19% | +$69.1K | 0.03% | 151 |
|
|
2023
Q1 | $366K | Sell |
9,847
-208
| -2% | -$7.73K | 0.03% | 199 |
|
|
2022
Q4 | $456K | Buy |
10,055
+4,435
| +79% | +$201K | 0.04% | 150 |
|
|
2022
Q3 | $393K | Sell |
5,620
-1,793
| -24% | -$125K | 0.04% | 188 |
|
|
2022
Q2 | $498K | Buy |
7,413
+4,092
| +123% | +$275K | 0.05% | 142 |
|
|
2022
Q1 | $273K | Buy |
+3,321
| New | +$273K | 0.01% | 231 |
|